WHX 2026
Join Vermon at WHX 2026, in Dubai, UAE, from February 9 to February 12, North Hall 21, K.92.
Dubai, UAE
We are proud to announce that Vermon has received the INPI Export Award 2025, a national recognition awarded by the French National Institute of Industrial Property (INPI). This distinction highlights companies whose intellectual property (IP) strategy actively supports international growth and technological innovation.
Selected in the Export category, Vermon was recognized for its ability to protect, develop, and deploy advanced ultrasound technologies on global markets through a strong and consistent IP approach.
Intellectual Property as a Driver of Global Growth
At Vermon, intellectual property protection is a core component of our innovation strategy. Operating in the highly competitive field of medical ultrasound and diagnostic imaging, we rely on patents, know-how, and technical expertise to secure our innovations and support long-term partnerships worldwide.
By aligning our R&D strategy with a structured IP framework, we ensure that our custom ultrasound transducers and high-performance ultrasound solutions can be reliably developed, industrialized, and exported while maintaining technological leadership.
Supporting French Innovation on International Markets
The INPI Export Award also recognizes Vermon’s contribution to the international reach of French medical technology. Designed and developed in France, our ultrasound innovations are used by medical imaging manufacturers and research partners across the world.
This award reflects the daily commitment of our teams and confirms the strategic role of intellectual property, patents, and innovation in building sustainable global success in the medical imaging and ultrasound sector.
WHX 2026
Join Vermon at WHX 2026, in Dubai, UAE, from February 9 to February 12, North Hall 21, K.92.
Dubai, UAE
Read More
EcoVadis Gold Medal 2025: Vermon Among the Top 5% of Rated Companies
Vermon has been awarded the EcoVadis Gold Medal 2025 for the second consecutive year, recognizing its strong commitment to Corporate Social Responsibility. This distinction places Vermon among the top 5% of companies worldwide, highlighting its continuous efforts in sustainability, ethics, and responsible business practices.
Read More
Multidisciplinary Group Awarded in France 2030 Plan to Develop Next-Generation Software-Based, Smart, and Frugal Ultrasound Imaging Devices
The POCUSI (Point of Care UltraSound for Screening & Intervention) consortium—bringing together E-Scopics, Vermon, IHU Strasbourg, and Inria—has been awarded funding under the France 2030 investment plan to develop a new generation of software-based, intelligent, and frugal ultrasound imaging devices.
With a total budget of €6.7 million over five years, the project aims to democratize point-of-care ultrasound, making advanced imaging accessible to non-expert operators throughout the patient care pathway. POCUSI focuses particularly on chronic liver diseases and metabolic disorders, enabling improved screening, monitoring, and image-guided interventions. By combining cutting-edge software, high-performance probes, clinical expertise, and data-driven simulation tools, POCUSI supports the emergence of a strategic and sustainable French digital ultrasound sector, strengthening France’s technological sovereignty in medical imaging.
Read More
RSNA 2025
Join Vermon at RSNA 2025 in Chicago, USA, from November 30 to December 4. Discover our latest ultrasound transducer innovations and meet our team in North Hall, Level 3 – Booth 8049.
CHICAGO, USA
Read More
MEDICA 2025
The world of medical technology meets again at MEDICA 2025! Visit Vermon in Hall 9, Booth 17, to explore our latest ultrasound innovations and learn how we’re advancing diagnostic imaging for better patient care.
DÜSSELDORF, GERMANY
Read More